IQVIA Holdings Inc (IQV)

255.87 -0.22  -0.09% NYSE Oct 27, 12:31 USD
View Full Chart
Price Chart
View All IQV News

News

View All Events

Events

Date Type Description
02/10/2022 Earnings Results Q4 2021 Earnings Results
02/10/2022 09:00 EST Earnings Calls Q4 2021 Earnings Call
10/21/2021 Earnings Results Q3 2021 Earnings Results
10/21/2021 09:00 EST Earnings Calls Q3 2021 Earnings Call
07/27/2021 Earnings Results Q2 2021 Earnings Results
07/27/2021 09:00 EST Earnings Calls Q2 2021 Earnings Call
04/22/2021 Earnings Results Q1 2021 Earnings Results
04/22/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
04/13/2021 09:00 EST AGM 2020 Annual General Meeting
02/10/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
  • URL: https://www.iqvia.com
  • Investor Relations URL: https://ir.iqvia.com
  • HQ State/Province: North Carolina
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Feb. 10, 2022
  • Last Earnings Release: Oct. 21, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
IBB iShares Biotechnology ETF 3.84%
FBT First Trust NYSE Arca Biotech ETF 3.45%
LGMNX Loomis Sayles Global Allocation N 2.81%
IGAF.TO IA Clarington Loomis Global Allc ETF 2.81%
CCM9721 IA Clarington Loomis Global Allc L5 (USD) 2.33%
VMGIX Vanguard Mid-Cap Growth Index Investor 1.28%
VOT Vanguard Mid-Cap Growth ETF 1.28%
PGODX Putnam Growth Opportunities R5 1.28%
SHISX BlackRock Health Sciences Opps Svc 1.26%
VIMSX Vanguard Mid Cap Index Investor 0.70%
VO Vanguard Mid-Cap ETF 0.67%
IWR iShares Russell Mid-Cap ETF 0.42%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.